Loading…
Viral Hepatitis Testing Act of 2014
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 3,002 other S bills in the 113th — cohort avg 39d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (3)
2015 · first_quarter · Health Issues
Discussions and proposals related to the 21st Century Cures initiative; Discussions to clarify or reform the 340B program; Biologics Price Competition and Innovation Act; H.R. 2031, TEST Act H.R. 1101, Viral Hepatitis Testing Act of 2015; S. 2538, Viral Hepatitis Testing Act of 2014; Proposals to improve viral hepatitis screening and testing; Public Law 111-148, The Patient Protection and Affordable Care Act; Implementation of The Prescription Drug User Fee Act (PDUFA);
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $1,870,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
2015 · first_quarter · Health Issues
Discussions and proposals related to the 21st Century Cures initiative; Discussions to clarify or reform the 340B program; Biologics Price Competition and Innovation Act; H.R. 2031, TEST Act H.R. 1101, Viral Hepatitis Testing Act of 2015; S. 2538, Viral Hepatitis Testing Act of 2014; Proposals to improve viral hepatitis screening and testing; Public Law 111-148, The Patient Protection and Affordable Care Act; Implementation of The Prescription Drug User Fee Act (PDUFA);
Client expense: $1,860,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
2014 · second_quarter · Health Issues
H.R. 3723 - Viral Hepatitis Testing Act S. 2538 - Viral Hepatitis Testing Act Biosimilars
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · second_quarter · Health Issues
H.R. 3723 - Viral Hepatitis Testing Act S. 2538 - Viral Hepatitis Testing Act Biosimilars
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Health Issues
H.R. 3723 - Viral Hepatitis Testing Act S. 2538 - Viral Hepatitis Testing Act Biosimilars FDA ReformH.R. 83 - Consolidated and Further Continuing Appropriations Act, 2015
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Health Issues
Discussions and proposals related to the 21st Century Cures initiative; Discussions to clarify or reform the 340B program; Biologics Price Competition and Innovation Act; H.R. 3723, Viral Hepatitis Testing Act of 2013; S. 2538, Viral Hepatitis Testing Act of 2014; Proposals to improve viral hepatitis screening and testing; Public Law 111-148, The Patient Protection and Affordable Care Act; Public Law 111-152, The Health Care and Education Reconciliation Act of 2010; Proposals to address prescription drug abuse; Implementation of The Prescription Drug User Fee Act (PDUFA);
Client expense: $1,010,000 · Firm income: Not reported
2014 · third_quarter · Health Issues
H.R. 3723 - Viral Hepatitis Testing Act S. 2538 - Viral Hepatitis Testing Act Biosimilars
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · second_quarter · Health Issues
H.R. 3723 - Viral Hepatitis Testing Act S. 2538 - Viral Hepatitis Testing Act Biosimilars
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Health Issues
Viral Hepatitis/HIV/AIDS Hep Action Plan H.R. 3723/S. 2538: Viral Hepatitis Testing Act Substance Abuse testing CMS Reimbursement
Client expense: Not reported · Firm income: $10,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS)
2014 · third_quarter · Health Issues
H.R. 3723 - Viral Hepatitis Testing Act S. 2538 - Viral Hepatitis Testing Act Biosimilars
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · second_quarter · Health Issues
H.R. 3723 - Viral Hepatitis Testing Act S. 2538 - Viral Hepatitis Testing Act Biosimilars
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, U.S. Trade Representative (USTR)